Naloxone Co-Prescribing Risk Calculator
Opioid Overdose Risk Assessment
This tool helps determine if naloxone co-prescribing is recommended based on CDC guidelines.
Patient Risk Factors
Risk Assessment Result
Every year, thousands of people in the U.S. die from opioid overdoses-not because they were using drugs illegally, but because they were taking prescribed pain medication. For many, the risk isn’t obvious. They’re following their doctor’s orders, managing chronic pain, and never imagined a simple pill could become deadly. That’s where naloxone co-prescribing comes in: a simple, life-saving step that’s now becoming standard care for patients on opioids.
What Is Naloxone Co-Prescribing?
Naloxone co-prescribing means giving a patient naloxone at the same time they receive an opioid prescription. Naloxone isn’t a painkiller. It’s an overdose reversal drug. When someone overdoses on opioids, their breathing slows or stops. Naloxone works fast-it pushes the opioids off the brain’s receptors and brings breathing back within minutes. It’s safe, non-addictive, and has no effect if opioids aren’t in the system.
This isn’t a new idea. The CDC first recommended it in 2016. Since then, it’s been backed by the American Medical Association, the Department of Health and Human Services, and even the World Health Organization. The goal? Make sure that if an overdose happens-whether by accident, mistake, or relapse-someone nearby can act before it’s too late.
Who Needs Naloxone With Their Opioid Prescription?
Not every patient on opioids needs naloxone. But many do. The CDC says you should offer it when any of these risk factors are present:
- Taking 50 morphine milligram equivalents (MME) or more per day
- Using benzodiazepines (like Xanax or Valium) at the same time
- Having a past overdose or substance use disorder
- Having COPD, sleep apnea, or other breathing problems
- Using alcohol heavily or having depression, anxiety, or other mental health conditions
- Recently been released from jail or prison
Why these? Because they make overdose more likely. Mixing opioids with benzodiazepines doubles the risk. High doses? A person on 90 MME/day has over twice the overdose risk of someone on 20 MME. And after jail? Tolerance drops fast. Someone who used to take opioids daily might not be able to handle the same dose anymore-and that’s when overdose hits hardest.
How Does Naloxone Work?
Naloxone is like a key that fits better into opioid receptors than the opioid itself. When you give it during an overdose, it kicks the opioid out and lets oxygen flow again. It doesn’t cause euphoria. It doesn’t make you high. It doesn’t cure addiction. It just gives you time.
There are two main forms used today:
- Intranasal spray (like Narcan® or Kloxxado™): Easy to use. No needle. Just spray into one nostril. Most patients and families prefer this.
- Injectable: Used in hospitals or by trained responders. Requires a syringe and injection into the arm or thigh.
Dosing is simple: 2 to 4 mg per dose. If there’s no response after 2-3 minutes, give a second dose. The spray lasts 30-90 minutes, but opioids can last longer. That’s why you must call 911 even after giving naloxone.
Real Impact: Numbers Don’t Lie
Studies show this works. In a 2019 study of nearly 2,000 patients, those who got naloxone with their opioid prescription had 47% fewer emergency room visits and 63% fewer hospital stays due to overdose. In rural Kentucky, one clinic documented 17 overdose reversals in two years-each one saved by a family member using the naloxone kit they were given.
At the national level, naloxone distribution has grown fast. From 2017 to 2018, prescriptions for naloxone jumped 114%. After the SUPPORT Act passed in 2018, Medicare and Medicaid started covering it with little to no copay. Generic versions hit the market in 2022, and prices dropped from $130 to under $50 per kit. Now, more pharmacies stock it-and more patients get it.
Why Some Patients Refuse It
Not everyone accepts it. In a 2021 survey, 68% of doctors said patients push back. Why? Stigma. Some think, “If you’re giving me naloxone, you think I’m going to overdose.” Others feel judged. A Reddit post from a physician assistant said 60% of their patients refuse.
But stories change minds. Sarah Johnson, a chronic pain patient in Ohio, was offended when her doctor offered naloxone with her oxycodone. Then her 16-year-old son found the pills and took them. He stopped breathing. Sarah used the nasal spray. He woke up. She later said, “That spray saved his life. Now I carry two.”
Family members feel safer too. A 2022 survey found 78% of caregivers felt more secure knowing naloxone was available. The problem? Only 38% of high-risk patients actually receive it-even though guidelines say they should.
How Clinicians Can Make It Work
Doctors aren’t always sure how to bring it up. Here’s how to do it right:
- Assess risk: Use your state’s Prescription Drug Monitoring Program (PDMP) to check opioid doses and other prescriptions. Look for benzodiazepines, past overdoses, or mental health diagnoses.
- Explain plainly: Don’t say, “You might overdose.” Say, “This is like a seatbelt. You hope you never need it, but if something happens, it helps.”
- Teach how to use it: Use the S.L.A.M. method: Signs of overdose (unresponsive, slow breathing, blue lips), Life-saving steps (call 911, check breathing), Address naloxone (spray or inject), Monitor until help arrives.
- Include family: Give instructions to spouses, kids, or roommates. Many overdoses happen at home.
Electronic health records (EHRs) now have templates for this. Sixty-three percent of large health systems use them. Standing orders in 49 states let pharmacists dispense naloxone without a new prescription-so even if the doctor forgets, the pharmacy can step in.
State Laws Are Changing Fast
As of 2024, 24 states require doctors to offer naloxone with opioid prescriptions. But the rules vary:
- New York: Offer naloxone to anyone getting an opioid prescription.
- California: Only if the dose is over 90 MME/day.
- Most states: Follow the CDC’s 50 MME/day rule.
Some states still don’t require it. That’s why access is uneven. Urban pharmacies stock naloxone 85% of the time. Rural ones? Only 42%. That gap kills.
What’s Next?
The federal government is doubling down. In 2023, HHS gave $100 million to distribute 1.2 million naloxone kits to community groups. The FDA approved the first generic nasal spray in April 2023, cutting costs further. A long-acting naloxone formulation is in Phase III trials-could last 48 hours instead of 90 minutes.
But the biggest barrier isn’t science. It’s habit. Doctors still hesitate. Patients still feel shame. Pharmacies still run out. We need more training, more funding, and more honest conversations.
Overdose isn’t always about addiction. Sometimes, it’s about a missed dose, a bad mix, or a child finding pills. Naloxone co-prescribing doesn’t mean giving up on pain management. It means being smart about it. It means saying, “I care enough to prepare for the worst.”
For patients on opioids, naloxone isn’t a sign of failure. It’s a safety net. And everyone deserves one.
